Delivered 41% revenue growth and 83% gross margin in Q4 2025; Improved Net Loss by 52% and achieved first-ever Adjusted EBITDA positivity in Q4 2025; FY2026 Revenue Guidance of $106-112 million, mid-p ...
Personalis (NASDAQ:PSNL) executives on the company’s fourth quarter 2025 earnings call highlighted accelerating clinical adoption of its ultra-sensitive NeXT Personal minimal residual disease (MRD) ...
In Colorado, as of 2025, about 500 people a year die from lung cancer as the result of radon gas exposure. Nationally, the number of lung cancer deaths attributed to radon is about 21,000 per year.
Thermo Fisher Scientific is launching a new test it says can help doctors avoid the “trial-and-error” approach typically used ...
Strategic focus shifted from cautious spending and scaling to a full embrace of growth, especially with the 170% test volume growth target for 2026 and a doubling of sales reps. Guidance language ...
Biodesix expects to deliver $106 million to $112 million in annual revenue for 2026, representing 23% growth at the midpoint over 2025. The guidance includes consideration of recent weather events and ...
Malaysia has a new national plan to tackle cancer, tuberculosis, and chronic respiratory conditions in a single approach. Jacqui Thornton reports.
Radon is a radioactive gas found in many homes and is the No. 1 cause of lung cancer in nonsmokers.
This press release is not intended for UK media HERNEXEOS (zongertinib tablets) approved based on an objective response rate of 76% (N=72) as demonstrated in the Beamion LUNG-1 clinical trial1 Acceler ...
The FDA has granted accelerated approval to zongertinib (Hernexeos) for the treatment of adults with unresectable or ...
The U.S. Food and Drug Administration (FDA) has approved Hernexeos (zongertinib) for adults with unresectable or metastatic non-squamous non-small cell lung cancer whose tumors have specific HER2 ...
BioAffinity Technologies said on Wednesday that it will run a study of its CyPath Lung test for early lung cancer detection in collaboration with Brooke Army Medical Center (BAMC). CyPath Lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results